semaglutide week by week (Wegovy) for the Treatment of Obesity STARTING MY SEMAGLUTIDE JOURNEY *week

Save Share Educate #GLP1ReceptorAgonists #IncretinTherapy #DiabetesPharmacology #ClinicalPharmacy #Endocrinology #MedEd #Type2Diabetes #WeightLoss #ASCVD To view or add a comment, sign in More Relevant Posts Post-Treatment Weight Regain Following GLP-1 Receptor Agonists, Dual GIP/GLP-1 Agonists, Centrally Acting Agents, and Lipase Inhibitors: Evidence from Semaglutide, Tirzepatide, Liraglutide, Orlistat, PhentermineTopiramate, and NaltrexoneBupropion Background & Objective Systematic review and meta-analysis assessing body weight and cardiometabolic changes after stopping weight-management medications (WMMs) in adults with overweight or obesity

Access to care is a huge barrier, whether it be to a health care provider or to access the medication, Reid says

Ketosis from steep or prolonged carb restriction produces acetone breath, and adding 15 to 30 grams of a slow carb once daily typically improves odor within 24 to 72 hours if ketones are the cause

Bioavailability is critical

Both have generally well-tolerated safety profiles in healthy patients without contraindications

The critical distinction: GLP-1 agonists modulate metabolism and hormonal signaling